AB-004 (Nanjing Aorui Pharmaceutical)

N/A

Report date: 2023/02/24 17:46:11
NME

Base Information

Drug NameAB-004 (Nanjing Aorui Pharmaceutical)
Drug Alias NameAB-004AB-004 (奥瑞药业)AB-004 (Nanjing Aorui Pharmaceutical)
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMyc proto-oncogene protein modulators
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Aorui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Aorui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A